Patent · US Active

Prostate kallikrein allergen

US9518987B2 · kind B2 · utility

0Cited by

3References

18Claims

0Family size

Assignee

PHADIA AB · SE

Inventors

Lars Mattsson · Uppsala, SE
Jonas Lidholm · Knivsta, SE
Henrik Everberg · Stockholm, SE

Key dates

Filing date	Nov 3, 2015
Grant date	Dec 13, 2016
Priority date	—
Expiry date	Nov 3, 2035

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/96455
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Methods for treatment of a Type I allergy in a mammal comprise administering to an individual in need of such treatment a polypeptide of SEQ ID NO: 1 or the mature protein, amino acids 25-260, of the polypeptide of SEQ ID NO: 1, or a fragment of the polypeptide or the mature protein, which fragment shares epitopes for antibodies with the polypeptide or the mature protein, respectively, or a hypoallergenic form thereof that is modified to abrogate or attenuate its IgE binding response. Diagnostic kits comprise the polypeptide of SEQ ID NO: 1 or the mature protein, amino acids 25-260, of the polypeptide of SEQ ID NO: 1, immobilized on a solid support.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.